Literature DB >> 8946201

Comparative genomic hybridization for genetic analysis of renal oncocytomas.

J C Presti1, H Moch, V E Reuter, D Huynh, F M Waldman.   

Abstract

Renal oncocytomas are uncommon tumors of the kidney that are considered to be of low malignant potential. Neither conventional cytogenetic nor restriction fragment length polymorphism analyses have identified consistent genetic alterations in their genomic DNA. The purpose of the present study was to identify the genetic alterations associated with the development of renal oncocytomas. We studied 13 renal oncocytomas by using comparative genomic hybridization, and we identified loss of genetic material from chromosomes 1 and/or 14 in six of these tumors. These alterations may represent early genetic events in the development of these tumors.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8946201     DOI： 10.1002/(SICI)1098-2264(199612)17:4<199::AID-GCC1>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


  10 in total

1.  Renal oncocytoma with a novel chromosomal rearrangement, der(13)t(13;16)(p11;p11), associated with a renal cell carcinoma.

Authors:  X Leroy; E Leteurtre; P H Mahe; B Gosselin; B Delobel; M F Croquette
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

Review 2.  [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].

Authors:  C Lüders; G Kristiansen
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

3.  [Cystic renal neoplasms. New entities and molecular findings].

Authors:  H Moch
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

4.  Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.

Authors:  Fredrik Petersson; Zoran Gatalica; Petr Grossmann; Maria Delia Perez Montiel; Isabel Alvarado Cabrero; Stela Bulimbasic; Anthony Swatek; Lubomir Straka; Tomas Tichy; Milan Hora; Naoto Kuroda; Ben Legendre; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2010-03-19       Impact factor: 4.064

5.  Evaluation of New Immunohistochemical Approaches for the Study of Kidney Tumors in Geriatric.

Authors:  T V Pavlova; N B Pilkevich; D V Bessmertnyi; I A Pavlov; D V Atiakshin; L A Pavlova
Journal:  Arch Razi Inst       Date:  2021-10-31

Review 6.  [Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].

Authors:  K D Mertz; J Tchinda; R Küfer; P Möller; M A Rubin; H Moch; S Perner
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

Review 7.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430

9.  Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors.

Authors:  Jill M Hagenkord; Anil V Parwani; Maureen A Lyons-Weiler; Karla Alvarez; Robert Amato; Zoran Gatalica; Jose M Gonzalez-Berjon; Leif Peterson; Rajiv Dhir; Federico A Monzon
Journal:  Diagn Pathol       Date:  2008-11-06       Impact factor: 2.644

10.  Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?

Authors:  Amin El-Heliebi; Thomas Kroneis; Evelyn Zöhrer; Johannes Haybaeck; Katja Fischereder; Karin Kampel-Kettner; Richard Zigeuner; Hannelore Pock; Regina Riedl; Rudolf Stauber; Jochen Bernd Geigl; Berthold Huppertz; Peter Sedlmayr; Carolin Lackner
Journal:  J Transl Med       Date:  2013-09-17       Impact factor: 5.531
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.